Steyrer E, Kostner G M
Institute of Medical Biochemisty, University of Graz, Austria.
J Lipid Res. 1990 Jul;31(7):1247-53.
The ability of different lipoprotein Lp[a] preparations to compete with LDL-binding to the B/E-receptor was investigated by ligand blot and filter assays. Lp[a] was purified from donors with various genetic polymorphic forms by affinity chromatography using lysine-Sepharose or specific immunoadsorbers. These preparations were free of "LDL-like" material. Part of Lp[a] was reduced and freed from specific apo[a] antigen yielding "Lpa-." 125I-labeled low density lipoproteins (LDL) were incubated with B/E-receptor preparations from bovine adrenal cortex or from human skin fibroblasts, and the competition with unlabeled LDL, Lp[a], Lpa-, apo[a], and apoE-free HDL was studied by a ligand blot or filter assay technique. The following results were obtained. 1) LDL and Lpa- were equally potent in displacing 125I-labeled from B/E-receptor in the ligand blot and the filter assay. Lpa + ( = Lp[a]) also displaced LDL but to a much lesser degree: 50% displacement was observed with LDL and Lpa- at a 1-fold excess, whereas a 7.5-fold excess was required of Lpa +. 2) Apo[a], as well as apoE-free HDL, did not compete with LDL binding. 3) Competition experiments using B/E-receptors from bovine adrenal cortex or from human skin fibroblasts were comparable. 4) There was no difference in the behavior of Lp[a] isolated from the two affinity chromatography methods. 5) Lp[a] of different genetic variants behaved virtually identically. The results are discussed from the point of view of the in vivo metabolism of Lp[a].
通过配体印迹法和滤膜分析,研究了不同脂蛋白Lp[a]制剂与低密度脂蛋白(LDL)竞争结合B/E受体的能力。利用赖氨酸-琼脂糖或特异性免疫吸附剂,通过亲和色谱法从具有不同基因多态性形式的供体中纯化Lp[a]。这些制剂不含“LDL样”物质。部分Lp[a]被还原并去除特异性载脂蛋白[a]抗原,得到“Lpa-”。将125I标记的低密度脂蛋白(LDL)与来自牛肾上腺皮质或人皮肤成纤维细胞的B/E受体制剂一起孵育,并通过配体印迹法或滤膜分析技术研究其与未标记的LDL、Lp[a]、Lpa-、载脂蛋白[a]和无载脂蛋白E的高密度脂蛋白(HDL)的竞争情况。得到以下结果。1)在配体印迹法和滤膜分析中,LDL和Lpa-在从B/E受体上取代125I标记物方面同样有效。Lpa +(=Lp[a])也能取代LDL,但程度要小得多:LDL和Lpa-以1倍过量时可观察到50%的取代,而Lpa +则需要7.5倍过量。2)载脂蛋白[a]以及无载脂蛋白E的HDL不与LDL结合竞争。3)使用来自牛肾上腺皮质或人皮肤成纤维细胞的B/E受体进行的竞争实验结果相当。4)从两种亲和色谱方法分离得到的Lp[a]的行为没有差异。5)不同基因变体的Lp[a]表现几乎相同。从Lp[a]的体内代谢角度对结果进行了讨论。